Experimental Investigations on a Sequential Combination Chemotherapy Protocol

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 1980 Jan 1

PMID 7358773

Authors

H O Klein

H J Toermer

E Christian

C COERPER

K J LENNARTZ

G AKOKAN

Affiliations

Soon will be listed here.

Abstract

This paper deals with experimental investigations concerning the composition of a cytostatic three-drug-protocol in diploid Ehrlich-Ascites-Tumor (EAT) cells in vivo at a far advanced stage of the disease. Hydroxyurea (HU) and vincristine (VCR) were used in very low doses to induce a modification of the growth pattern of tumor cells alike partial synchronization. Adriamycin (ADM) was selected as cytocidal drug during DNA synthesis of the partially synchronized cells. It was found that the sequential combination of HU and VCR (first HU and 12 h thereafter VCR) caused the greatest alteration of growth pattern compared with other combination protocols. A further statistically significant increase of the degree of synchrony was observed after a second VCR administration -- 22 h after HU. By means of this protocol the EAT was subdivided into two proliferating subpopulations, a diploid and tetraploid one. The tetraploid population resulted from surviving cells being not able to perform dytokinesis correctly, so that polynuclear cells and cells with a large single nucleus containing tetraploid DNA values were created. With respect to therapy, the administation of ADM at the time of DNA synthesis of the partially synchronized cells resulted in a statistically significant prolongation of the mean survival time and in 30% of cures of the animals. The dosage of ADM was 2.6 mg/kg, i.e., a nonlethal dose (50% of the LD10). Other combinations, i.e., simultaneous or reversed sequential combinations, did not show any therapeutic improvement compared to single drug therapy of ADM.

References

Jellinghaus W, Schultze B, Maurer W . The effect of vincristine on mouse jejunal crypt cells of differing cell age: double labelling autoradiographic studies using 3H- and 14C-TdR. Cell Tissue Kinet. 1977; 10(2):147-56. DOI: 10.1111/j.1365-2184.1977.tb00140.x. View

WHEELER G, BOWDON B, Adamson D, VAIL M . Comparison of the effects of several inhibitors of the synthesis of nucleic acids upon the viability and progression through the cell cycle of cultured H. Ep. no. 2 cells. Cancer Res. 1972; 32(12):2661-9. View

Silvestrini R, Gambarucci C, Dasdia T . [Biological activity of adriamycin in vitro]. Tumori. 1970; 56(3):137-48. DOI: 10.1177/030089167005600301. View

Plagemann P, Richey D, Zylka J, Erbe J . Thymidine transport by Novikoff rat hepatoma cells synchronized by double hydroxyurea treatment. Exp Cell Res. 1974; 83(2):303-10. DOI: 10.1016/0014-4827(74)90343-7. View

Singer R, GELFANT S . Continuous inhibition of DNA synthesis in mouse ear epidermis using hydroxyurea. Exp Cell Res. 1972; 73(1):270-1. DOI: 10.1016/0014-4827(72)90135-8. View

Sartorelli A, Creasey W . Cancer chemotherapy. Annu Rev Pharmacol. 1969; 9:51-72. DOI: 10.1146/annurev.pa.09.040169.000411. View

Silvestrini R, Di Marco A, Dasdia T . Interference of daunomycin with metabolic events of the cell cycle in synchronized cultures of rat fibroblasts. Cancer Res. 1970; 30(4):966-73. View

Bosmann H . Antineoplastic drug activity in the mitotic cycle--effects of six agents on macromolecular synthesis in synchronous mammalian leukemic cells. Biochem Pharmacol. 1972; 21(14):1977-88. DOI: 10.1016/0006-2952(72)90010-x. View

Sinclair W . Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle. Science. 1965; 150(3704):1729-31. DOI: 10.1126/science.150.3704.1729. View

10.

Wilms K, Wilmanns W . [Effects of dauno-rubidomycin and adriamycin on enzymes of DNA synthesis in leukocytes in vivo and in culture]. Klin Wochenschr. 1972; 50(18):866-70. DOI: 10.1007/BF01488943. View

11.

Tobey R . Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse. Cancer Res. 1972; 32(12):2720-5. View

12.

MADOC-JONES H, Mauro F . Age responses to x rays, Vinca alkaloids, and hydroxyurea of murine lymphoma cells synchronized in vivo. J Natl Cancer Inst. 1970; 45(6):1131-43. View

13.

Rajewsky M . Synchronisation in vivo: kinetics of a malignant cell system following temporary inhibition of DNA synthesis with hydroxyurea. Exp Cell Res. 1970; 60(2):269-76. DOI: 10.1016/0014-4827(70)90514-8. View

14.

GILLETTE E, Withers H, Tannock I . The age sensitivity of epithelial cells of mouse small intestine. Radiology. 1970; 96(3):639-43. DOI: 10.1148/96.3.639. View

15.

Kim J, Gelbard A, Perez A . Action of hydroxyurea on the nucleic acid metabolism and viability of HeLa cells. Cancer Res. 1967; 27(7):1301-5. View

16.

TERASIMA T, Tolmach L . Growth and nucleic acid synthesis in synchronously dividing populations of HeLa cells. Exp Cell Res. 1963; 30:344-62. DOI: 10.1016/0014-4827(63)90306-9. View

17.

Byfield J, Scherbaum O . A rapid radioassay technique for cellular suspensions. Anal Biochem. 1966; 17(3):434-43. DOI: 10.1016/0003-2697(66)90179-5. View

18.

Kim S, Kim J . Lethal effect of adriamycin on the division cycle of HeLa cells. Cancer Res. 1972; 32(2):323-5. View

19.

Negishi T, TAKAHIRA H . [Incorporation of adriamycin into cell nuclei and interaction between adriamycin and DNA (author's transl)]. Yakugaku Zasshi. 1973; 93(11):1498-508. DOI: 10.1248/yakushi1947.93.11_1498. View

20.

BRAUNSCHWEIGER P, Schiffer L . Cell kinetics after vincristine treatment of C3H/He spontaneous mammary tumors: implications for therapy. J Natl Cancer Inst. 1978; 60(5):1043-8. DOI: 10.1093/jnci/60.5.1043. View